Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Jessner lymphocytic infiltration of the skin (JLIS) is a chronic benign cutaneous disease characterized by asymptomatic non-scaly erythematous papules or plaques on the face and neck.
Features include very common findings: Erythema, Papule, and Skin plaque; and common findings: Pruritus, Cutaneous photosensitivity, and Abnormal lymphocyte morphology.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 5 | Pruritus, Cutaneous photosensitivity, Erythema |
Phenotype severity distribution: 3 very common features, 3 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Jessner lymphocytic infiltration of the skin.
10 publications have been identified in PubMed for Jessner lymphocytic infiltration of the skin. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (20%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 50% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Jessner lymphocytic infiltration of the skin
Research summaries
2 |
20% |
Disease patterns and progression | 2 | 20% |
New treatment approaches | 1 | 10% |
Mumcu N (2026). [PMID: 41903296](https://pubmed.ncbi.nlm.nih.gov/41903296/). *Diagn Microbiol Infect Dis*. [Case Report / Case Series]
Montes Belloso ME (2026). [PMID: 41558140](https://pubmed.ncbi.nlm.nih.gov/41558140/). *Semergen*. [Epidemiology / Natural History]
Prenner J (2025). [PMID: 39714826](https://pubmed.ncbi.nlm.nih.gov/39714826/). *JAMA dermatology*. [Case Report / Case Series]
Daruish M (2024). [PMID: 38611691](https://pubmed.ncbi.nlm.nih.gov/38611691/). *Diagnostics (Basel, Switzerland)*. [Review / Meta-Analysis]
Camisa C (2024). [PMID: 38803774](https://pubmed.ncbi.nlm.nih.gov/38803774/). *Cureus*. [Review / Meta-Analysis]
Landau M (2024). [PMID: 38470410](https://pubmed.ncbi.nlm.nih.gov/38470410/). *Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]*. [Gene Therapy / Novel Therapeutics]
Chow KL (2024). [PMID: 39079206](https://pubmed.ncbi.nlm.nih.gov/39079206/). *Seminars in arthritis and rheumatism*. [Epidemiology / Natural History]
Li L (2024). [PMID: 38633469](https://pubmed.ncbi.nlm.nih.gov/38633469/). *Clinical, cosmetic and investigational dermatology*. [Case Report / Case Series]
Kurashige T (2024). [PMID: 38734636](https://pubmed.ncbi.nlm.nih.gov/38734636/). *BMC immunology*. [Case Report / Case Series]
Garcia B (2024). [PMID: 39015404](https://pubmed.ncbi.nlm.nih.gov/39015404/). *Case reports in dermatology*. [Case Report / Case Series]